In the 2016 WHO classification, anaplastic astrocytomas were differentiated into IDH-mutant and IDH-wildtype; the latter, lacking the IDH mutation, had a significantly worse prognosis (behaving like glioblastoma) [9]. This evidence concerns the gene IDH1 and glioblastoma.